Self-management of oral anticoagulation in children with congenital heart disease

Research output: Contribution to journalJournal articlepeer-review

Standard

Self-management of oral anticoagulation in children with congenital heart disease. / Christensen, T D; Attermann, J; Hjortdal, V E; Maegaard, M; Hasenkam, J M.

In: Cardiology in the Young, Vol. 11, No. 3, 05.2001, p. 269-76.

Research output: Contribution to journalJournal articlepeer-review

Harvard

Christensen, TD, Attermann, J, Hjortdal, VE, Maegaard, M & Hasenkam, JM 2001, 'Self-management of oral anticoagulation in children with congenital heart disease', Cardiology in the Young, vol. 11, no. 3, pp. 269-76. https://doi.org/10.1017/s1047951101000282

APA

Christensen, T. D., Attermann, J., Hjortdal, V. E., Maegaard, M., & Hasenkam, J. M. (2001). Self-management of oral anticoagulation in children with congenital heart disease. Cardiology in the Young, 11(3), 269-76. https://doi.org/10.1017/s1047951101000282

Vancouver

Christensen TD, Attermann J, Hjortdal VE, Maegaard M, Hasenkam JM. Self-management of oral anticoagulation in children with congenital heart disease. Cardiology in the Young. 2001 May;11(3):269-76. https://doi.org/10.1017/s1047951101000282

Author

Christensen, T D ; Attermann, J ; Hjortdal, V E ; Maegaard, M ; Hasenkam, J M. / Self-management of oral anticoagulation in children with congenital heart disease. In: Cardiology in the Young. 2001 ; Vol. 11, No. 3. pp. 269-76.

Bibtex

@article{e7cee01d9ead432f9af9cbd5bf470881,
title = "Self-management of oral anticoagulation in children with congenital heart disease",
abstract = "OBJECTIVE: The concept of self-management of oral anticoagulation has been shown to entail better quality of treatment than conventional management when assessed in selected adults. We have extended the concept of self-management to include children with congenital cardiac disease, hypothesizing self-management of oral anticoagulation is also possible in this subset of patients. Our aim was to assess the quality of self-management.METHODS: We trained 14 children aged from 2.2 to 15.6 years, with a mean age of 9.7 years, and their parents, in domiciliary analysis of the International Normalized Ratio and necessary adjustment of dosage of coumarin. The curriculum for training lasted for 27 weeks, and the patients and their parents were followed for a period of up to 31 months by weekly measurement of the values obtained for the International Normalized Ratio.RESULTS: The patients were observed over a mean of 547 days, with a range from 214 to 953 days. The patients were within the therapeutic targetted range of the International Normalized Ratio for a median of 65.5% of the time, with a range from 17.6% to 90.4%. None of the patients experienced thromboembolic or bleeding complications requiring doctoral intervention. All the patients and their parents expressed full satisfaction with the treatment.CONCLUSION: Self-management of oral anticoagulation provides a good quality of treatment, which is feasible and safe in selected children with congenital cardiac disease.",
keywords = "Administration, Oral, Adolescent, Adult, Anticoagulants/administration & dosage, Calibration, Child, Child Welfare, Child, Preschool, Female, Heart Defects, Congenital/drug therapy, Humans, International Normalized Ratio, Male, Self Care/psychology, Treatment Outcome",
author = "Christensen, {T D} and J Attermann and Hjortdal, {V E} and M Maegaard and Hasenkam, {J M}",
year = "2001",
month = may,
doi = "10.1017/s1047951101000282",
language = "English",
volume = "11",
pages = "269--76",
journal = "Cardiology in the Young",
issn = "1047-9511",
publisher = "Cambridge University Press",
number = "3",

}

RIS

TY - JOUR

T1 - Self-management of oral anticoagulation in children with congenital heart disease

AU - Christensen, T D

AU - Attermann, J

AU - Hjortdal, V E

AU - Maegaard, M

AU - Hasenkam, J M

PY - 2001/5

Y1 - 2001/5

N2 - OBJECTIVE: The concept of self-management of oral anticoagulation has been shown to entail better quality of treatment than conventional management when assessed in selected adults. We have extended the concept of self-management to include children with congenital cardiac disease, hypothesizing self-management of oral anticoagulation is also possible in this subset of patients. Our aim was to assess the quality of self-management.METHODS: We trained 14 children aged from 2.2 to 15.6 years, with a mean age of 9.7 years, and their parents, in domiciliary analysis of the International Normalized Ratio and necessary adjustment of dosage of coumarin. The curriculum for training lasted for 27 weeks, and the patients and their parents were followed for a period of up to 31 months by weekly measurement of the values obtained for the International Normalized Ratio.RESULTS: The patients were observed over a mean of 547 days, with a range from 214 to 953 days. The patients were within the therapeutic targetted range of the International Normalized Ratio for a median of 65.5% of the time, with a range from 17.6% to 90.4%. None of the patients experienced thromboembolic or bleeding complications requiring doctoral intervention. All the patients and their parents expressed full satisfaction with the treatment.CONCLUSION: Self-management of oral anticoagulation provides a good quality of treatment, which is feasible and safe in selected children with congenital cardiac disease.

AB - OBJECTIVE: The concept of self-management of oral anticoagulation has been shown to entail better quality of treatment than conventional management when assessed in selected adults. We have extended the concept of self-management to include children with congenital cardiac disease, hypothesizing self-management of oral anticoagulation is also possible in this subset of patients. Our aim was to assess the quality of self-management.METHODS: We trained 14 children aged from 2.2 to 15.6 years, with a mean age of 9.7 years, and their parents, in domiciliary analysis of the International Normalized Ratio and necessary adjustment of dosage of coumarin. The curriculum for training lasted for 27 weeks, and the patients and their parents were followed for a period of up to 31 months by weekly measurement of the values obtained for the International Normalized Ratio.RESULTS: The patients were observed over a mean of 547 days, with a range from 214 to 953 days. The patients were within the therapeutic targetted range of the International Normalized Ratio for a median of 65.5% of the time, with a range from 17.6% to 90.4%. None of the patients experienced thromboembolic or bleeding complications requiring doctoral intervention. All the patients and their parents expressed full satisfaction with the treatment.CONCLUSION: Self-management of oral anticoagulation provides a good quality of treatment, which is feasible and safe in selected children with congenital cardiac disease.

KW - Administration, Oral

KW - Adolescent

KW - Adult

KW - Anticoagulants/administration & dosage

KW - Calibration

KW - Child

KW - Child Welfare

KW - Child, Preschool

KW - Female

KW - Heart Defects, Congenital/drug therapy

KW - Humans

KW - International Normalized Ratio

KW - Male

KW - Self Care/psychology

KW - Treatment Outcome

U2 - 10.1017/s1047951101000282

DO - 10.1017/s1047951101000282

M3 - Journal article

C2 - 11388620

VL - 11

SP - 269

EP - 276

JO - Cardiology in the Young

JF - Cardiology in the Young

SN - 1047-9511

IS - 3

ER -

ID: 243520065